Anna Jonebring

Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes

Anna-Karin Sjögren, Maria Liljevald, Björn Glinghammar et al. · Archives of Toxicology · 2014 · 78 citations

Life Sciences, Cell Biology, Toxicology +17

A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell–derived kidney model for drug discovery

Cecilia Boreström, Anna Jonebring, Jing Guo et al. · Kidney International · 2018 · 71 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience

Paul A. De Sousa, Rachel Steeg, Elisabeth Wächter et al. · Stem Cell Research · 2017 · 63 citations · Full text

Life Sciences, Biotechnology, Cell Biology +16

Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells

Mei Ding, Henrik Andersson, Sofia Martinsson et al. · Scientific Reports · 2020 · 52 citations · Full text

Engineering, Bioengineering, Cell Biology +17

Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-<i>β</i> Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation

Lauren Drowley, Chad H. Koonce, S Peel et al. · Stem Cells Translational Medicine · 2015 · 37 citations · Full text

Life Sciences, Cardiology, Cell Biology +15